RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
Hamilton, New Jersey, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer | HER2-positive Early-stage Breast Cancer | Recruiting | Phase 2 | 2026-04-23 | NCT07402473 | |
| Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric adenocarcinoma, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 2 | 2026-01-20 | NCT03257163 | |
| Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Recruiting | Phase 2 | 2025-11-14 | NCT05559164 | |
| DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment | Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, skin disorder | Recruiting | Phase 4 | 2025-11-13 | NCT07158164 |